Rosenbloom S - Search Results

1

Using Patient-reported Outcomes to Compare Relative Burden of Cancer: EQ-5D and Functional Assessment of Cancer Therapy-General in Eleven Types of Cancer.

Pickard AS, Jiang R, Lin HW, Rosenbloom S, Cella D. Pickard AS, et al. Among authors: rosenbloom s. Clin Ther. 2016 Apr;38(4):769-77. doi: 10.1016/j.clinthera.2016.03.009. Epub 2016 Apr 1. Clin Ther. 2016. PMID: 27041407

2

Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.

Pickard AS, De Leon MC, Kohlmann T, Cella D, Rosenbloom S. Pickard AS, et al. Among authors: rosenbloom s. Med Care. 2007 Mar;45(3):259-63. doi: 10.1097/01.mlr.0000254515.63841.81. Med Care. 2007. PMID: 17304084

3

Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice.

Rosenbloom SK, Victorson DE, Hahn EA, Peterman AH, Cella D. Rosenbloom SK, et al. Psychooncology. 2007 Dec;16(12):1069-79. doi: 10.1002/pon.1184. Psychooncology. 2007. PMID: 17342789 Clinical Trial.

4

Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy.

Butt Z, Rosenbloom SK, Abernethy AP, Beaumont JL, Paul D, Hampton D, Jacobsen PB, Syrjala KL, Von Roenn JH, Cella D. Butt Z, et al. J Natl Compr Canc Netw. 2008 May;6(5):448-55. doi: 10.6004/jnccn.2008.0036. J Natl Compr Canc Netw. 2008. PMID: 18492460 Free PMC article.

5

Age-associated differences in fatigue among patients with cancer.

Butt Z, Rao AV, Lai JS, Abernethy AP, Rosenbloom SK, Cella D. Butt Z, et al. J Pain Symptom Manage. 2010 Aug;40(2):217-23. doi: 10.1016/j.jpainsymman.2009.12.016. Epub 2010 Jun 11. J Pain Symptom Manage. 2010. PMID: 20541901 Free PMC article.

6

Efficient assessment of the most important symptoms in advanced prostate cancer: the NCCN/FACT-P Symptom Index.

Victorson DE, Beaumont JL, Rosenbloom SK, Shevrin D, Cella D. Victorson DE, et al. Psychooncology. 2011 Sep;20(9):977-83. doi: 10.1002/pon.1817. Epub 2010 Jul 25. Psychooncology. 2011. PMID: 20661866

7

Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.

Cella D, Rosenbloom SK, Beaumont JL, Yount SE, Paul D, Hampton D, Abernethy AP, Jacobsen PB, Syrjala K, Von Roenn JH. Cella D, et al. J Natl Compr Canc Netw. 2011 Mar;9(3):268-78. doi: 10.6004/jnccn.2011.0026. J Natl Compr Canc Netw. 2011. PMID: 21393439 Free PMC article.

8

Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).

Garcia SF, Rosenbloom SK, Beaumont JL, Merkel D, Von Roenn JH, Rao D, Cella D. Garcia SF, et al. Value Health. 2012 Jan;15(1):183-90. doi: 10.1016/j.jval.2011.08.1739. Epub 2011 Oct 26. Value Health. 2012. PMID: 22264987 Free article.

9

Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI).

Butt Z, Parikh ND, Beaumont JL, Rosenbloom SK, Syrjala KL, Abernethy AP, Benson AB 3rd, Cella D. Butt Z, et al. Cancer. 2012 Dec 1;118(23):5997-6004. doi: 10.1002/cncr.27588. Epub 2012 May 17. Cancer. 2012. PMID: 22605658 Free PMC article.

10

Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D.

Pickard AS, Kohlmann T, Janssen MF, Bonsel G, Rosenbloom S, Cella D. Pickard AS, et al. Among authors: rosenbloom s. Med Care. 2007 Sep;45(9):812-9. doi: 10.1097/MLR.0b013e31805371aa. Med Care. 2007. PMID: 17712251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page